Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14,410 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of Mindfulness-Based Cognitive Therapy With Follow-Up Sessions for Pharmacotherapy-Refractory Anxiety Disorders: Protocol for a Feasibility Randomized Controlled Trial.
Sado M, Ninomiya A, Nagaoka M, Koreki A, Goto N, Sasaki Y, Takamori C, Kosugi T, Yamada M, Park S, Sato Y, Fujisawa D, Nakagawa A, Mimura M. Sado M, et al. Among authors: sato y. JMIR Res Protoc. 2022 Jan 21;11(1):e33776. doi: 10.2196/33776. JMIR Res Protoc. 2022. PMID: 34787573 Free PMC article.
Trends of concerns from diagnosis in patients with advanced lung cancer and their family caregivers: A 2-year longitudinal study.
Sato T, Fujisawa D, Arai D, Nakachi I, Takeuchi M, Nukaga S, Kobayashi K, Ikemura S, Terai H, Yasuda H, Kawada I, Sato Y, Satomi R, Takahashi S, Hashiguchi MH, Nakamura M, Oyamada Y, Terashima T, Sayama K, Saito F, Sakamaki F, Inoue T, Naoki K, Fukunaga K, Soejima K. Sato T, et al. Among authors: sato y. Palliat Med. 2021 May;35(5):943-951. doi: 10.1177/02692163211001721. Epub 2021 Mar 24. Palliat Med. 2021. PMID: 33761790 Free PMC article.
Cost-effectiveness analyses of augmented cognitive behavioral therapy for pharmacotherapy-resistant depression at secondary mental health care settings.
Sado M, Koreki A, Ninomiya A, Kurata C, Mitsuda D, Sato Y, Kikuchi T, Fujisawa D, Ono Y, Mimura M, Nakagawa A. Sado M, et al. Among authors: sato y. Psychiatry Clin Neurosci. 2021 Nov;75(11):341-350. doi: 10.1111/pcn.13298. Epub 2021 Sep 17. Psychiatry Clin Neurosci. 2021. PMID: 34459077 Free PMC article. Clinical Trial.
Longitudinal Assessment of Prognostic Understanding in Patients with Advanced Lung Cancer and Its Association with Their Psychological Distress.
Arai D, Sato T, Nakachi I, Fujisawa D, Takeuchi M, Sato Y, Kawada I, Yasuda H, Ikemura S, Terai H, Nukaga S, Inoue T, Nakamura M, Oyamada Y, Terashima T, Sayama K, Saito F, Sakamaki F, Naoki K, Fukunaga K, Soejima K. Arai D, et al. Among authors: sato t, sato y. Oncologist. 2021 Dec;26(12):e2265-e2273. doi: 10.1002/onco.13973. Epub 2021 Sep 23. Oncologist. 2021. PMID: 34510654 Free PMC article.
Japanese Project for Telepsychiatry Evaluation during COVID-19: Treatment Comparison Trial (J-PROTECT): Rationale, design, and methodology.
Kishimoto T, Kinoshita S, Bun S, Sato Y, Kitazawa M, Kikuchi T, Sado M, Takamiya A, Mimura M, Nakamae T, Abe Y, Kanazawa T, Kawabata Y, Tomita H, Abe K, Hishimoto A, Asami T, Suda A, Watanabe Y, Amagai T, Sakuma K, Kida H, Funayama M, Kimura H, Sato A, Fujiwara S, Nagao K, Sugiyama N, Takamiya M, Kodama H, Azekawa T; J-PROTECT Collaborators. Kishimoto T, et al. Among authors: sato a, sato y. Contemp Clin Trials. 2021 Dec;111:106596. doi: 10.1016/j.cct.2021.106596. Epub 2021 Oct 13. Contemp Clin Trials. 2021. PMID: 34653648 Free PMC article.
Group multi-component programme based on cognitive behavioural therapy and positive psychology for family caregivers of people with dementia: a randomised controlled study (3C study).
Tamura NT, Shikimoto R, Nagashima K, Sato Y, Nakagawa A, Irie S, Iwashita S, Mimura M, Fujisawa D. Tamura NT, et al. Among authors: sato y. Psychogeriatrics. 2023 Jan;23(1):141-156. doi: 10.1111/psyg.12919. Epub 2022 Nov 28. Psychogeriatrics. 2023. PMID: 36443896 Clinical Trial.
A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Efficacy and Safety of Eculizumab in Patients with Guillain-Barré Syndrome (GBS): Protocol of Japanese Eculizumab Trial for GBS (JET-GBS).
Yamaguchi N, Misawa S, Sato Y, Nagashima K, Katayama K, Sekiguchi Y, Iwai Y, Amino H, Suichi T, Yokota T, Nishida Y, Kohara N, Hirata K, Nishiyama K, Yabe I, Kaida KI, Suzuki N, Nodera H, Tsuji S, Koike H, Kira JI, Hanaoka H, Kusunoki S, Kuwabara S; JET-GBS Group. Yamaguchi N, et al. Among authors: sato y. JMIR Res Protoc. 2016 Nov 7;5(4):e210. doi: 10.2196/resprot.6610. JMIR Res Protoc. 2016. PMID: 27821382 Free PMC article.
14,410 results
You have reached the last available page of results. Please see the User Guide for more information.